303 related articles for article (PubMed ID: 8508979)
1. [Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer].
von Minckwitz G; Kaufmann M
Gynakologe; 1993 Apr; 26(2):100-6. PubMed ID: 8508979
[No Abstract] [Full Text] [Related]
2. [Steroid receptor status as prognostic factor in ovarian cancer].
Schieder K; Biegelmayer C; Kölbl H; Breitenecker G
Gynakol Rundsch; 1990; 30 Suppl 1():65-7. PubMed ID: 2079302
[No Abstract] [Full Text] [Related]
3. [Prognostic factors in breast cancer].
Jonat W; Eidtmann H; Friedrichs K
Gynakologe; 1994 Feb; 27(1):37-44. PubMed ID: 8168736
[No Abstract] [Full Text] [Related]
4. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
Graeff H; Jänicke F
Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
[No Abstract] [Full Text] [Related]
5. [Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast].
Schmid KW; Hittmair A; Tötsch M; Müller E; Zaimet A; Tauscher T; Dünser M; Ofner D
Gynakol Rundsch; 1990; 30 Suppl 1():150-1. PubMed ID: 2079251
[No Abstract] [Full Text] [Related]
6. [Significance of the proliferative activity of breast cancer for prognosis and therapy].
Pickartz H
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):993-4. PubMed ID: 1776291
[No Abstract] [Full Text] [Related]
7. [Cell receptors and proliferation markers in breast cancer].
Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
[No Abstract] [Full Text] [Related]
8. [The effect of transport conditions on biochemically and immunohistochemically determined steroid hormone receptor content in breast cancer].
Remmele W; Schicketanz KH
Pathologe; 1993 Jan; 14(1):21-4. PubMed ID: 8383846
[No Abstract] [Full Text] [Related]
9. [Steroid hormone receptor status and other immunohistochemical prognostic markers in benign and malignant diseases of the breast].
Nizze H; al-Thobhani AK; Terpe H
Zentralbl Chir; 1998; 123 Suppl 5():14-8. PubMed ID: 10063564
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical detection of estrogen and progesterone receptors in paraffin sections].
Snijders M; Theunissen P; Debets-Te Baerts M; Koudstaal J
Pathologe; 1990 Jul; 11(4):236-9. PubMed ID: 2204912
[No Abstract] [Full Text] [Related]
11. Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival.
Bhatavdekar JM; Patel DD; Karelia NH; Trivedi SN; Shah NG; Vora HH; Ghosh N; Balar DB
Neoplasma; 1992; 39(6):349-52. PubMed ID: 1491724
[TBL] [Abstract][Full Text] [Related]
12. [Quantitative determination of steroid hormone receptors in breast cancer tissue outside tumor centers].
Prechtel D; Prechtel K
Pathologe; 1993 Jan; 14(1):16-20. PubMed ID: 8451222
[No Abstract] [Full Text] [Related]
13. [Estrogen and progesterone receptors as prognostic markers in endometrial carcinoma].
Gorchev G; Milkov V
Akush Ginekol (Sofiia); 1992; 31(2):32-3. PubMed ID: 1342555
[TBL] [Abstract][Full Text] [Related]
14. [Determination of steroid hormone receptors with the biochemical DCC method in endometrial cancer and tumor margin-endometrium relations to cellular changes and hormone level].
Martin R; Köhler U; Krug H; Rotzsch W
Geburtshilfe Frauenheilkd; 1993 May; 53(5):314-20. PubMed ID: 8514102
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
16. [Rate of proliferation as a prognostic criterion in endometrial carcinoma--an immunohistochemical analysis with the monoclonal antibody KI-S1].
Backe J; Gassel AM; Müller T; Schön S; Kaesemann H
Zentralbl Gynakol; 1997; 119(7):334-42. PubMed ID: 9340973
[TBL] [Abstract][Full Text] [Related]
17. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
18. Correlation of steroid receptors in synchronous tissues with survival in breast cancer patients.
Bhatavdekar JM; Patel DD; Karelia NH; Suthar TP; Shah NG; Vora HH; Ghosh N; Nadkarni SP; Balar DB
Neoplasma; 1993; 40(3):177-80. PubMed ID: 8350965
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
Seifert M; Wierrani F; Kubista E; Spona J
Gynakol Rundsch; 1991; 31 Suppl 2():397-8. PubMed ID: 1790992
[No Abstract] [Full Text] [Related]
20. [Thermolabile characteristics of steroid hormone receptors in breast cancer].
Merkle E; Bähr I; Tulusan AH; Lang N
Geburtshilfe Frauenheilkd; 1991 Mar; 51(3):182-5. PubMed ID: 2055391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]